07:00 , Jul 21, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Cell division cycle 34 homolog (CDC34); S-phase kinase-associated protein 2 (SKP2) An in vitro study suggests...
07:00 , Jul 21, 2011 |  BC Innovations  |  Targets & Mechanisms

Celgene skips SKP2

Celgene Corp.and academic collaboratorshave designed the firstsmall molecule inhibitor of an E2 component in the ubiquitin pathway.1Despite positive data in vitro, the team thinks it will be difficult to optimize the cancer therapeutic for the...